Probiotics and Antibiotics: Timing Matters

Sensitive populations: This article references pediatric. Always confirm any supplement change with your child's pediatrician before starting — dosing, contraindications, and risk profile shift in these groups.

The advice to take probiotics with antibiotics is so common it has become reflexive. The evidence is more nuanced than the habit suggests: timing, strain choice, and what you are trying to prevent all decide whether probiotics help, do nothing, or even slow the gut's own recovery once the antibiotic course ends. There is a reasonable case for taking specific probiotics during a course to prevent diarrhoea, and a counterintuitive case for not reaching for them purely to "rebuild" the microbiome afterwards.

Why antibiotics disrupt the gut microbiome

Antibiotics are not selective weapons. Broad-spectrum agents sharply reduce the diversity and abundance of commensal gut bacteria within days of the first dose. That disruption is the underlying cause of antibiotic-associated diarrhoea (AAD), reported in roughly 5–35% of antibiotic users depending on the drug and population, and of the most serious complication, Clostridioides difficile infection. C. difficile remains one of the most common healthcare-associated infections; the US Centers for Disease Control and Prevention has estimated on the order of 200,000–225,000 hospitalized cases annually, with community-associated infections also a concern. This is the clinical problem probiotics are marketed to solve — and where the strongest evidence for them actually lies.

Where probiotics clearly help: preventing diarrhoea during treatment

The strongest case is for taking specific probiotics alongside the antibiotic course to prevent diarrhoea. A 2017 Cochrane review (Goldenberg and colleagues) pooled 31 randomized trials and 8,672 patients and found probiotic co-administration reduced the risk of C. difficile-associated diarrhoea by about 60% (risk ratio 0.40), with a number-needed-to-treat of 42 across all patients. The benefit was concentrated in higher-risk patients: among trials where the baseline risk of C. difficile diarrhoea exceeded 5%, the reduction was about 70% and the number-needed-to-treat fell to roughly 12. The certainty of the evidence was rated moderate, and — importantly — probiotics did not reduce actual C. difficile infection rates, only the diarrhoeal syndrome.

For ordinary antibiotic-associated diarrhoea (not specifically C. difficile), the picture is similar. A 2017 meta-analysis of outpatient trials found AAD in 8% of probiotic users versus 18% of controls (risk ratio 0.49), and a 2019 Cochrane review in children pooled 33 trials and reported AAD in 8% versus 19% (risk ratio 0.45, number-needed-to-treat 9), with higher doses (≥5 billion CFU/day) more effective than lower ones. The two strains with the most consistent evidence — and the only two with strong guideline backing from the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) — are Lacticaseibacillus rhamnosus GG and Saccharomyces boulardii. Most generic "probiotic" products on the shelf do not specify a strain or a dose, and the evidence does not transfer to them.

Timing: why the gap between doses matters

Bacterial probiotics are themselves vulnerable to antibacterial drugs, so taking a Lactobacillus capsule in the same mouthful as an antibiotic can kill much of the dose before it does anything. The practical rule is to separate bacterial probiotics from the antibiotic by at least two hours. S. boulardii is the exception that makes timing easy: it is a yeast, not a bacterium, so antibacterial drugs do not kill it, and it can be taken at the same time as the antibiotic. Whichever you choose, the trials that showed benefit generally started the probiotic close to the first antibiotic dose and continued it for the duration of the course (and often a week or two beyond), rather than starting only after the antibiotics finished.

The counterintuitive part: probiotics may slow microbiome recovery afterwards

Preventing diarrhoea during treatment is a different goal from restoring the microbiome afterwards, and the evidence pulls in opposite directions. A 2018 study in Cell (Suez and colleagues at the Weizmann Institute) examined the gut mucosa directly in humans and mice after antibiotics. Counterintuitively, the group given a multi-strain probiotic showed a markedly delayed and incomplete return of their native gut bacteria and gene-expression profile, whereas a group given an autologous faecal microbiome transplant (a reinfusion of the person's own pre-antibiotic stool bacteria) recovered within days. The probiotic strains appeared to colonize and crowd out the returning indigenous community. The mechanistic takeaway: probiotics taken purely to "rebuild" the microbiome after a course may delay the very recovery they are sold to support. This was a small, invasive study and should not be over-generalized, but it is a useful corrective to the assumption that more probiotic is always better.

What actually rebuilds the microbiome

For longer-term recovery after the course ends, dietary diversity — fermented foods, a range of prebiotic fibres, and varied plant intake — is the better-supported approach, providing the substrate that a person's own resident bacteria use more efficiently than transient imported strains. The honest summary: use a well-characterized strain (LGG or S. boulardii) during a course if you are at risk of antibiotic-associated diarrhoea, mind the two-hour gap for bacterial strains, and then lean on food rather than capsules to restore diversity afterwards.